<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">World Allergy Organ J</journal-id><journal-id journal-id-type="iso-abbrev">World Allergy Organ J</journal-id><journal-id journal-id-type="publisher-id">wox</journal-id><journal-title-group><journal-title>The World Allergy Organization Journal</journal-title></journal-title-group><issn pub-type="epub">1939-4551</issn><publisher><publisher-name>World Allergy Organization Journal</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3541796</article-id><article-id pub-id-type="doi">10.1097/01.WOX.0000426363.63147.d3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts of the XXII World Allergy Congress</subject></subj-group><subj-group subj-group-type="heading"><subject>Poster Symposium</subject></subj-group><series-title>Allied Health</series-title></article-categories><title-group><article-title>177&#x02003;Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents With Hypertriglyceridemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Berreondo</surname><given-names>Nancy Mendez</given-names></name></contrib></contrib-group><aff>3204, Distrito Federal, Mexico.</aff><pub-date pub-type="epub"><day>17</day><month>2</month><year>2012</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2012</year></pub-date><volume>5</volume><issue>Suppl 2</issue><issue-title>Abstracts of the XXII World Allergy Congress, 4&#x02013;8 December, 2012 Canc&#x000fa;n, M&#x000e9;xico</issue-title><fpage seq="a">S76</fpage><lpage>S76</lpage><permissions><copyright-statement>Copyright &#x000a9; 2012 by World Allergy Organization</copyright-statement><copyright-year>2012</copyright-year></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="waoj-5-S76.pdf"/><abstract><sec><title>Background</title><p>Evaluate the effect of supplementation of eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA) in FEV<sub>1</sub> and triglyceride levels in obese adolescents.</p></sec><sec><title>Methods</title><p>Single blinded, parallel, clinical trial in 2 groups of adolescents supplemented with an intake of 3 gm/d of EPA-DHA versus 3 gm of grenetin for 3 months. We included adolescents with exogenous obesity with Body Mass Index (BMI) CDC &#x0003e; 95%. All patients underwent anthropometry, lipid profile and spirometry at baseline and study end. They were divided into 2 groups: G1: EPA-DHE obese and G2: Grenetin obese. Samples analyzed by T Student (paired and independent).</p></sec><sec><title>Results</title><p>Adolescents were recruited with hypertriglyceridemia &#x0003e; 150 mg/dl, female 45.5%, male 54.5% mean and SD 12 &#x000b1; 1.3 years. There were 34 patients in G1 and G2: 40 patients. The initial values averages the baseline IC 95% FEV<sub>1</sub> G1 102.27 (106.06&#x02013;98.48), G2 102.18 (106.12&#x02013;98.26), Tiffaneau Index G1: 0.87 (0.90&#x02013;0.84), G2 0.85 (0.83&#x02013;0.88) Triglycerides G1 221.71 (246.10&#x02013;197.32), G2 190.91 (206.90&#x02013;174.92), Cholesterol G1 169.29 (179.35&#x02013;159.23), G2 157.09 (169.90&#x02013;144.28), HDL G1 32.96 (35.58&#x02013;30.36), G2 33.85 (36.55&#x02013;31.06). After 3 months, FEV<sub>1</sub> G1 100.39 (104.99&#x02013;95.79), G2 100.80 (105.88&#x02013;95.74), Tiffaneau Index G1 0.83 (0.85&#x02013;0.81), G2 0.86 (0.86&#x02013;0.83) Triglycerides G1 101.00 (117.64&#x02013;84.36), G2 127.09 (149.87&#x02013;104.31), Cholesterol G1 169.88 (181.70&#x02013;158.06), G2 163.32 (176.00&#x02013;148.64), HDL G1 35.95 (40.25&#x02013;31.66), G2 35.81 (38.93&#x02013;32.71). Supplementation with EPA-DHA and grenetine for 3 months in triglyceride basal levels had only one significant value (<italic>P</italic> &#x0003c; 0.05), without a significant in FEV1.</p></sec><sec><title>Conclusions</title><p>Supplementation with EPA-DHA and grenetine for 3 months is helpful for reducing basal levels of triglycerides.</p></sec></abstract></article-meta></front></article>